Platinum Account Group’s Forecast on the Global Biotechnology Market
Platinum Account Group believes if there is a growth in the biotechnology instrumentation market, meaning there is also an increase in the number of research projects and in addition to this, the growth will also be filled up by the surging worldwide demand for innovative drugs and therapies, which in turn is driving the growth of the drug discovery research.
Over the next few years, Platinum Account Group is expecting that the market for biotechnology instrumentation will see a strong growth with the biotech and pharmaceutical companies seeking more cultivated and detailed analysis.
Platinum Account Group is a privately-owned company that offers you the highest quality of advice and financial service in the industry. We assist knowledgeable and discerning investors who seek the highest return on their investment. We are a wholly independent company and our contribution and service for our client’s wealth management and financial planning purposes is not restricted to particular funds or investment products we may want to implement.
PLATINUM ACCOUNT GROUP
2 Floor Street West, Toronto, ON ,Canada, M4W 3E2
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Platinum Account Group’s Forecast on the Global Biotechnology Market here
News-ID: 217772 • Views: 1148
More Releases from PLATINUM ACCOUNT GROUP
Platinum Account Group’s Forecast on the Global Biotechnology Market
Platinum Account Group can see that the healthcare and biotechnology remained the least affected sector from the recent global economic recession. Something like this is very impressive because the global economic recession has affected almost all the industries around the world. In fact, several of the major biotech companies quickly overcame and kicked back from the recessionary impact, and post positive gains. Biotech research growth in pharmaceutical operations, agriculture environmental
Platinum Account Group excited about Apple’s TV Business Plan
Excitement recently flew through the office of Prosumis upon knowing of Apple Inc’s (AAPL) plan to branch out into the TV business that causes a big move into display manufacturing. On March 23, Taiwan’s Hon Hai Group agreed to invest 133 billion yen, equivalent to $1.6 billion USD, in Sharp Corporation LTD (SHCAY). Sharp is a Japanese company that is a major producer of thin film transistor liquid crystal displays
Platinum Account Group’s Outlook on Annual Copper Prices
Last year, Platinum Account Group witnessed the negative performance of copper in the market. In the first half of 2011, prices of copper traded in a small range between $4 per pound and $4.4 per pound and even worse in August where the price has dropped almost $1 per pound. However, there is positive outlook for copper this year. Copper is now completely linked to the Chinese growth story. Platinum
Platinum Account Group: $15 Million Funds of oDesk
For those who are still not familiar with oDesk, it is an online workplace that’s enabling businesses and contractors work together without geographic limits. Today, oDesk is growing rapidly and now became the globe’s largest and fastest growing online workplace where it has received $15 million in Series D funding. Platinum Account Group reports that oDesk is now considered one of the largest workplaces than all other online workplaces combined.
More Releases for Biotech
Global Acetaminophen (Paracetamol) Market 2020 | Genesis Biotech, M.M. Pharma, A …
The Global Acetaminophen (Paracetamol) Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The study provides company profiling, product picture and specifications, sales, market share and contact information of key manufacturers of Global Acetaminophen (Paracetamol) Market.The Key manufactures involved in this market
Global Phycobiliprotein Market 2017 Norland Biotech, Algapharma Biotech, Phyco-B …
Global Phycobiliprotein Market Report 2017 Phycobiliprotein industrial chain, this report mainly elaborate the definition, types, applications and major players of Phycobiliprotein market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the
GLOBAL PHYCOBILIPROTEIN MARKET- DAINIPPON INK AND CHEMICALS, PHYCO-BIOTECH 2 COL …
Global Industry Study Evaluate on Phycobiliprotein Market by Type Manufacturers Regions and Application Forecast up to 2022 The scope of the Phycobiliprotein Report: This report primarily focuses on Phycobiliprotein in the global market. This report generally covers Phycobiliprotein market in North America Phycobiliprotein market in Asia-Pacific Phycobiliprotein market in Europe Phycobiliprotein market in Latin America Middle as well as Africa. This report partitions the Phycobiliprotein market based on Application Manufacturers Countries as
Harver Group Targets BioTech Bull
Synta Pharmaceuticals has a bullish outlook for Q3-Q4; insider buying indicates the company will be releasing positive research results and see a gain in returns. Jul. 24, 2013 - CHUO-KU, Japan -- Due to the huge increase in staff and board members buying stock in Synta Pharmaceuticals, and the successful trials of Synta Pharmaceuticals latest cancer drug Ganetespib, Pharmaceutical Analysts at Harver Group are now strongly recommending the stock as a
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Biotech APIs Showing Insurgent Growth
According to a new research report by RNCOS entitled, “Global Biotech API Market Analysis”, the rapidly growing and innovating biopharmaceuticals and biotechnology industry as a whole is putting the biotech API industry into charts of insurgent growth. Research Analysis & Highlights The report, “Global Biotech API Market Analysis”, spread over 55 pages, provides an in-depth research and rational analysis of the current and expected status of the biotech API industry across the